Ramaswamy has organized many events in several counties in Iowa and New Hampshire, but his polling numbers have not increased. Here you have details of the...
Vivek Ramaswamy
Biographical Data, Vivek Ramaswamy |
|
|---|---|
| Age | 37 Years Old |
| Height | 5.7ft |
| Weight | 71kgs |
| Eye Colour | Black |
| Hair Colour | Black |
| Wife | Apoorva Tewari |
| Religion | Hindu |
Facts About Vivek Ramaswamy
- Vivek Ramaswami was born in 1985 in Cincinnati, Ohio, United States.
- He graduated summa cum laude from Harvard University with a degree in molecular and cellular biology.
- Ramaswami received his Ph.D. in biology from the Massachusetts Institute of Technology (MIT).
- He worked as a consultant at McKinsey & Company, a management consulting firm, before founding Roivant Sciences in 2014.
- Roivant Sciences is a biopharmaceutical company that aims to develop and commercialize innovative therapies for diseases with unmet medical needs. In 2017, Roivant Sciences went public, raising $1.2 billion in its initial public offering (IPO).
- Ramaswami is also the founder of several other biotech companies, including Axovant Sciences and Myovant Sciences.
- In 2019, Ramaswami was named to Forbes' 30 Under 30 in Healthcare list.
- He has also been recognized as a Young Global Leader by the World Economic Forum.
- Ramaswami is an active investor in the biotech industry, and he has invested in several biotech companies, including Relay Therapeutics and Kymera Therapeutics.
Relevant People & Companies
Recent News About Vivek Ramaswamy
If you’re looking to watch Vivek Ramaswamy hosts a presidential campaign event in Des Moines, you’ve stumbled upon the perfect page. Biotech...
Born in Cincinnati, Ohio, biotech entrepreneur Vivek Ramaswamy gained global prominence when he announced his intention to run for the Republican nomination in...
The militant Palestinian group Hamas, in control of the Gaza Strip, targeted key Israeli cities, including Jerusalem and Tel Aviv, and launched a flurry of...
Vivek Ramaswamy, a Republican running for president, spoke on Monday about a “pro-American Movement” to a full ballroom in Rock Hill. Vivek...
The United States rising politician Vivek Ramaswamy has revealed how illegal migrants enter the U.S. and threaten the country’s security. Here are the...
Republican 2024 Presidential hopeful is backing former President Donald Trump’s nomination for the new United States House Speaker. Here are the details...
Biotech entrepreneur Vivek Ramaswamy is supposed to offer a jaw-dropping salary of 100K$ to hire a nanny for his kids. Here are the details of the news. Is...
A Republican 2024 presidential hopeful requests the RNC to adjust the rules for the third debate. Here are the details of the news. Vivek Ramaswamy’s...
In the second Republican presidential debate, Indian-American presidential candidate Vivek Ramaswamy said he would support abolishing birthright citizenship...
During the second GOP presidential primary debate, Vivek Ramaswamy was repeatedly criticized by his opponents for having business ties to China. With six other...
Republican presidential candidate Vivek Ramaswamy addressed the Mackinac Republican Leadership Conference, which was hosted at the Grand Hotel on Mackinac...
Vivek Ramaswamy, 38, acquired citizenship by birthright because he was born in the United States to two noncitizens, and his parents entered the country...
The emerging Republican Presidential hopeful has unveiled his Crypto policy framework to be executed when he becomes President of the United States in 2024...
In another Interview, American-Indian candidate Vivek Ramaswamy says, “People annoyed by my rise.” Let’s read the news and find out more...
Vivek Ramaswamy, the businessman-turned-candidate, discussed his plans with NBC News ahead of a significant policy speech at the America First Policy Institute...
A 38-year-old businessman and candidate for the Republican presidential nomination, Vivek Ramaswamy, announced on Friday that he would deport children of...
Vivek Ramaswamy, a Republican presidential candidate, and MSNBC host Mehdi Hasan engaged in a heated argument on Tuesday when Ramaswamy tried to dodge...
A week ago in Milwaukee, at the first Republican presidential debate, the two engaged in a tense interaction that sparked the barbs. Mike Pence called...
Donald Trump, the leading front-runner, praised Vivek Ramaswamy, a Republican presidential candidate of 38 years old. Former President Trump complimented Vivek...
Vivek Ramaswamy Net Worth
According to Forbes reports, Vivek Ramaswamy’s net worth is estimated at $950 million, although he has declined to disclose exactly how much he is worth. According to the Wall Street Journal, the biotech entrepreneur has over half a billion net worth.
Ramaswamy is the founder and CEO of Roivant Sciences, an organization valued at $6.54 billion. According to Forbes, this company is a biotech holding that develops drugs, often by purchasing abandoned pharmaceuticals and redeveloping them.
Ramaswamy co-founded Strive Asset Management last year to expand his business portfolio. Currently, he is the Executive Chairman of the company.
Vivek Ramaswamy Biography
Vivek Ramaswamy is an American entrepreneur who works in biotech and pharmaceuticals. He founded and runs Roivant Sciences, an innovative medicine company. He is also known for his bold business strategies and his ability to raise large amounts of money for his ventures. In 2024, he will be a candidate for president of the United States as a Republican.
Ramaswamy was born in Cincinnati, Ohio, in 1985, into an Indian immigrant family. He earned a degree in molecular biology from Harvard University before going to Yale Law School. After graduation, he gained experience in hedge fund management and financial analysis at the investment firm QVT Financial.
Roivant Sciences, founded by Ramaswamy in 2014, became one of the most talked-about startups in the biotech industry. The company has received over $2 billion in funding and is known for its unconventional approach to drug development. Instead of developing drugs from scratch, Roivant acquires and repurposes existing drugs developed by others.
